INTERLEUKIN-6 AND AGING - BLOOD-LEVELS AND MONONUCLEAR CELL PRODUCTION INCREASE WITH ADVANCING AGE AND IN-VITRO PRODUCTION IS MODIFIABLE BYDIETARY RESTRICTION
Wb. Ershler et al., INTERLEUKIN-6 AND AGING - BLOOD-LEVELS AND MONONUCLEAR CELL PRODUCTION INCREASE WITH ADVANCING AGE AND IN-VITRO PRODUCTION IS MODIFIABLE BYDIETARY RESTRICTION, Lymphokine and cytokine research, 12(4), 1993, pp. 225-230
Interleukin-6 (IL-6) is a multifunctional cytokine that is proving to
be a major contributor to the acute phase inflammatory response. IL-6
expression is normally low and serum levels are usually nondetectable
in the absence of inflammation. With advancing age, however, serum lev
els become detectable and it is proposed that this reflects an age-ass
ociated loss in the normal regulation of gene expression for this mole
cule. There is also speculation that IL-6 may contribute to the pathog
enesis of several diseases that are common in late-life including lymp
homa, osteoporosis, and Alzheimer's disease. In this report we demonst
rate that plasma levels of IL-6 rise with advancing age in well-select
ed healthy elderly people and comparably in old rhesus monkeys. That t
his change reflects a primary aging process is suggested by our findin
gs in C57BL/6 mice in which the age-associated increase in the in vitr
o synthesis of IL-6 is largely prevented by life span-extending dietar
y restriction.